The renal excretion of digitoxin was studied in cardiac patients who were (1) decompensated and (2) compensated. It was found that the renal excretion of digitoxin was not changed in patients suffering from left ventricular failure alone but diminished considerably during the first 24 hours of decompensation in patients suffering from both right and left ventricular failure. Patients who were maintained in a good state of compensation by adequate digitalization were found to excrete 30 to 40 per cent of their daily dose of digitoxin. Patients overdigitalized were found to excrete 70 or more micrograms of digitoxin a day. The maximal amount of digitoxin able to be destroyed in the body was considered to be approximately 50 gg. per day, a finding which explains why dosages in excess of 0.15 mg. almost invariably lead to overdigitalization. R ECENTLY, we have been able to determine in a direct, quantitative fashion the renal excretion of digitoxin in the rat,' rabbit and dog,2 and in normal man. 3 The results left little doubt that the normal young adult, unlike the animals studied, excreted a considerable fraction (approximately 40 per cent) of administered digitoxin in his urine. The individual over 60 years of age on the other hand, was found to excrete digitoxin poorly, at least during the first 24 hours following its administration.
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These observations, however, did not yield any information concerning the renal excretion of the glycoside by the cardiac patient either (1) when he was decompensated, or (2) when he was being maintained in a state of compensation by administration of digitoxin. Renal studies, therefore, were done on such patients and the results of these studies are presented below. MIETHIODS A. Selection of Subjects and Patients 1) Normal Subjects. Nine normal middle-aged subjects (37 to 66 years) were picked purposely in order that the control data would be obtained on subjects whose age was similar to that of the cardiac patients. These patients were given 1 Urine was collected daily for three consecutive days. Each sample was assayed separately.
2) Patients in Acute Cardiac Decompensation. Eight patients suffering from acute left ventricular failure, and eight from both left and right ventricular failure were given 1.2 mg. of digitoxin (Crystodigin) either orally or parenterally within a period of six hours and the total daily urine was collected when possible for three days. None of these patients had been taking digitalis or one of its glycosides before.
Patients suffering from acute left ventricular failure were chosen for this study if, besides the presence of organic heart disease, they suffered from (1) dyspnea, tachypnea, orthopnea, at least one attack of pulmonary edema, and (2) prolongation of circulation time (arm to tongue), an accentuated pulmonic second sound and basal pulmonary rales.
Right ventricular failure was considered to be present in those patients who exhibited signs of increased venous pressure, hepatomegaly, or an accumulation of extravascular fluid in the tissues or in the pleural or peritoneal cavities.
3) Compensated Cardiac Patients. A urine collection of 24 hours was made on 18 cardiac patients each of whom previously had suffered from one or more bouts of congestive failure but who had been maintained in a state of compensation by adequate digitoxin therapy (0.1 to 0.15 mg. per day) for periods varying from 2 to 60 months preceding our studies. A patient was considered adequately digitalized and well compensated if there were no indications of excess extravascular fluid, increasing dyspnea or orthopnea, tachycardia, or pulse deficit. The electrocardiograms of almost all of these patients exhibited some depression of the S-T segment in the limb leads indicative of medication with the digitalis glycoside.
A urine collection also was made on four chronic cardiac patients at the time they exhibited signs and symptoms of overdosage with digitoxin. 
B. Assay of Digitoxin in Urine
The digitoxin content of the daily urine was determined by previously described methods.3 Briefly, this process consisted of extracting known amounts of added digitoxin (1 to 12 micrograms) from fixed quantities of urine (200 cc.), brought to a standard specific gravity of 1.015. The final extracts were dissolved in Tyrode's solution (50 cc.). The Tyrode's solution was warmed to, and maintained at, 33 C.
After standards for various quantities of digitoxin in urine had been established in this manner, 200 cc. samples of urine containing an unknown amount of digitoxin could be extracted and assayed by comparing the results obtained with those previously obtained from the standard known values. The total daily excretion then was calculated by multiplying the amount of digitoxin found in the 200 cc. quantity of urine by the total daily urine volume/ and then six or more embryonic duck hearts were added. The average time at which the "digitalis effect"' occurred in these hearts was noted for each extraction. Thus, for example, a series of 15 extracts of 200 cc. quantities of urine originally containing 2 micrograms of digitoxin were observed to produce a "digitalis effect" in a period of 47 minutes (standard error of mean: :1:2.3 minutes); whereas 10 extracts of 10 different urine samples containing 4 micrograms produced a "digitalis effect" in 27 minutes (standard error of mean: 1: 1.5 minutes).
200. Urines which were too dilute or too concentrated were adjusted by evaporation or dilution respectively until a 200 cc. quantity had a specific gravity of 1.015 before the extraction process itself was begun.
RESULTS
A. Patients in Acute Failure 1) Left Ventricular Failure. Renal excretion of digitoxin was not diminished in patients 855;. suffering from acute left ventricular failure. The average urinary excretion in eight patients during the first three days after either oral or parenteral administration of 1.2 mg. of digitoxin was 39, 42, and 46 micrograms per day, respectively. As table 1 illustrates, this daily rate of excretion (about 3 per cent of the total dose) was approximately the same as that found in the control subjects. It is of interest too, that renal excretion of the glycoside was as extensive after oral as after parenteral administration of the drug.
2) Left and Right Ventricular Failure. Apparently the onset of right ventricular failure markedly diminished renal excretion of digitoxin for at least the first 24 hours after administration of the drug. Thus (see table 1), the average renal excretion in eight patients suffering from both right and left ventricular failure was only 19 micrograms (1.6 per cent of administered dose) during the first 24 hours. However, after the first day, the average renal excretion increased so that at the end of the third day, the renal excretion of digitoxin in the three patients studied was about equal to that of the patient with left ventricular failure or the normal subject.
B. Compensated Cardiac Patients
Chronic cardiac patients whose compensation was being maintained by administration of digitoxin were found (see table 2) to excrete an average of 41 micrograms of digitoxin (rangre: 21 to 56 micrograms) in their urine per day. This amount represented approximately 36 per cent (range: 21 to 56 per cent) of their average daily dose (0.12 mg.) of digitoxin.
Four patients who exhibited signs of overdosage with digitoxin excreted over twice as much digitoxin (average: 99 micrograms) in their daily urine. lDISCUSSION The above results suggest that the cardiac patient suffering from acute left ventricular failure excretes digitoxin in his urine as well, and in as great an amount, as the normal subject. Moreover, the renal rate is the same whether the drug is given by mouth or vein suggesting that there is probably complete gastrointestinal absorption of the drug.
On the other hand, a patient with combined right and left ventricular failure, is not able to excrete as much administered digitoxin during the first 24 hours as the normal subject. Whether this is due to some type of renal dysfunctioii secondary to venous congestion or to a greater escape of digitoxin in swollen extravascular compartments was not determined. The observed decrease in excretion, however, was of brief duration and after 24 hours, digitoxin was excreted in normal quantities. It is our opinion that this resumption of a normal rate of renal excretion of the glycoside was associated with the advent of diuresis.
The cardiac patient who was maintained in a state of compensation by the daily ingestion of digitoxin, excreted just about the same amount of glycoside (41 micrograms) as the normal individual (who was given the same amount of digitoxin) was found' to do. The cardiac patient, similar again to the normal individual, exhibited an excess of digitoxin in his urine (70 or more micrograms per day) whenever he exhibited clinical signs of overdosage with the drug. Using this urinary assay, we have been able to determine whether adequate or excessive digitalization existed in doubtful cases. Such assays proved to be very accurate as judged by later clinical observation.
It is of interest that the patient does not appear to excrete a maximum fraction of administered digitoxin until after about 1.2 mg. of the drug ostensibly has been accumulated in his tissues. Thus, only about 3 to 5 per cent of an initial dose of digitoxin (regardless of whether 0.2 or 1.2 mg. is giveii3) is excreted in the first day's urine. However, if after an initial dose of 1.2 mg. has been given, the patient or subject is maintained on 0.1 mg. or more per day, 30 to 40 per cent of this daily dose is excreted in the daily urine. This fraction appears to represent the maximum capacity of the kidney to rid the body of digitoxin. Thus, although an average of 99 micrograms of digitoxin was found in the daily urines of our four toxic patients, this still represented only 36 per cent of the average amount of the drug given to these patients. This fraction then appears fixed when relatively moderate quantities of digitoxin are given to a digitalized patient but whether this same fraction of a much larger dose also would be excreted by the kidney cannot be answered by our present data.
The fraction of digitoxin not excreted by the kidney (60 to 70 per cent of a given dose) is either excreted in the bile or destroyed in the body. An earlier study4 has indicated that not more than 10 per cent of a given dose is excreted in the bile of man. Therefore, the body apparently can destroy about 50 per cent of a daily dose of 0.1 mg. of digitoxin (about 50 micrograms per day). This appears to be about the maximal capacity for destruction of digitoxin by the body, for when 0.2 mg. or more digitoxin is given per day (see also previous study3), despite the increased amount renally excreted, the amount still left for parenchymal destruction (over 50 micrograms) appears to be too great for the very limited internal processes of destruction, and toxicity results.
These results shed considerable light upon the problem of elimination of digitalis by the digitalized patient. Pardee5 believed that administered digitalis disappeared from the body solely by excretion and he postulated that the maximal rate of elimination was about 0.13
Gm. of digitalis per day. Gold and De Graff6 on the other hand, concluded that the patient excreted only a percentage (possibly fixed) of the total amount of digitalis in the body. Our own observations indicate that the patient excretes a fixed percentage either of the total amount of digitalis in the body or of the daily amount given after adequate digitalization has been obtained. Just as important perhaps is the discovery that a fixed but very small amount also is probably destroyed in the body.
The rather fixed fraction of digitoxin excreted by the kidney and the sharply limited ability of the body to destroy no more than half of 100 micrograms of the drug per day explain the ease with which overdosage with this drug can occur. The excretory and neutral-izing powers of man thus appear to be narrow and inelastic in respect to the handling of this steroid.
SUMMARY
Patients suffering from acute left ventricular failure, excrete digitoxin as efficiently as normal subjects of the same age period. The addition of right ventricular failure, however, diminished renal excretion of digitoxin markedly but for only 24 hours. Compensated cardiac patients excrete digitoxin at the same rate as the normal subj ect (30 to 40 per cent of the daily dose). The patient who exhibits toxicity from overdosage with digitoxin, excretes over twice as much digitoxin as the adequately digitalized patient. On the basis of these results, the probable maximal capacity of the body to destroy digitoxin is about 50 micrograms per day.
